Newly emerging viruses, such as severe acute respiratory syndrome coronavirus (SARS-CoV), Middle Eastern respiratory syndrome CoVs (MERS-CoV), and H7N9, cause fatal acute lung injury (ALI) by driving hypercytokinemia and aggressive inflammation through mechanisms that remain elusive. In SARS-CoV/macaque models, we determined that anti–spike IgG (S-IgG), in productively infected lungs, causes severe ALI by skewing inflammation-resolving response. Alveolar macrophages underwent functional polarization in acutely infected macaques, demonstrating simultaneously both proinflammatory and wound-healing characteristics. The presence of S-IgG prior to viral clearance, however, abrogated wound-healing responses and promoted MCP1 and IL-8 production and proinflammatory monocyte/macrophage recruitment and accumulation. Critically, patients who eventually died of SARS (hereafter referred to as deceased patients) displayed similarly accumulated pulmonary proinflammatory, absence of wound-healing macrophages, and faster neutralizing antibody responses. Their sera enhanced SARS-CoV–induced MCP1 and IL-8 production by human monocyte–derived wound-healing macrophages, whereas blockade of FcγR reduced such effects. Our findings reveal a mechanism responsible for virus-mediated ALI, define a pathological consequence of viral specific antibody response, and provide a potential target for treatment of SARS-CoV or other virus-mediated lung injury.
Li Liu, Qiang Wei, Qingqing Lin, Jun Fang, Haibo Wang, Hauyee Kwok, Hangying Tang, Kenji Nishiura, Jie Peng, Zhiwu Tan, Tongjin Wu, Ka-Wai Cheung, Kwok-Hung Chan, Xavier Alvarez, Chuan Qin, Andrew Lackner, Stanley Perlman, Kwok-Yung Yuen, Zhiwei Chen
Title and authors | Publication | Year |
---|---|---|
Early Safety Indicators of COVID-19 Convalescent Plasma in 5,000 Patients
Michael J. Joyner, R. Scott Wright, DeLisa Fairweather, Jonathon W. Senefeld, Katelyn A. Bruno, Stephen A. Klassen, Rickey E. Carter, Allan M. Klompas, Chad C. Wiggins, John R.A. Shepherd, Robert F. Rea, Emily R. Whelan, Andrew J. Clayburn, Matthew R. Spiegel, Patrick W. Johnson, Elizabeth R. Lesser, Sarah E. Baker, Kathryn F. Larson, Juan G. Ripoll, Kylie J. Andersen, David O. Hodge, Katie L. Kunze, Matthew R. Buras, Matthew N.P. Vogt, Vitaly Herasevich, Joshua J. Dennis, Riley J. Regimbal, Philippe R. Bauer, Janis E. Blair, Camille M. van Buskirk, Jeffrey L. Winters, James R. Stubbs, Nigel S. Paneth, Nicole C. Verdun, Peter Marks, Arturo Casadevall |
Journal of Clinical Investigation | 2020 |
Serum interleukin-6 is an indicator for severity in 901 patients with SARS-CoV-2 infection: a cohort study
J Zhang, Y Hao, W Ou, F Ming, G Liang, Y Qian, Q Cai, S Dong, S Hu, W Wang, S Wei |
Journal of Translational Medicine | 2020 |
Persistent lentivirus infection induces early myeloid suppressor cells expansion to subvert protective memory CD8 T cell response✰,✰✰
L Liu, Q Lin, J Peng, J Fang, Z Tan, H Tang, K Kwan, K Nishiura, J Liang, H Kwok, Z Du, J Sun, K Liu, KY Yuen, H Wang, Z Chen |
EBioMedicine | 2020 |
Early Humoral Response Correlates with Disease Severity and Outcomes in COVID-19 Patients
AM Hashem, A Algaissi, SA Almahboub, MA Alfaleh, TS Abujamel, SS Alamri, KA Alluhaybi, HI Hobani, RH AlHarbi, RM Alsulaiman, MZ ElAssouli, S Hala, NK Alharbi, RY Alhabbab, AA AlSaieedi, WH Abdulaal, A Bukhari, AA AL-Somali, FS Alofi, AA Khogeer, A Pain, AA Alkayyal, NA Almontashiri, BM Ahmad, X Li |
Viruses | 2020 |
From Anti-SARS-CoV-2 Immune Responses to COVID-19 via Molecular Mimicry
D Kanduc |
Antibodies | 2020 |
Why does COVID-19 disproportionately affect older people?
AL Mueller, MS McNamara, DA Sinclair |
Aging | 2020 |
I mmunosenescence and Inflammaging: Risk Factors of Severe COVID-19 in Older People
AJ Pietrobon, FM Teixeira, MN Sato |
Frontiers in immunology | 2020 |
Autoinflammatory and autoimmune conditions at the crossroad of COVID-19
Y Rodríguez, L Novelli, M Rojas, MD Santis, Y Acosta-Ampudia, DM Monsalve, C Ramírez-Santana, A Costanzo, WM Ridgway, AA Ansari, ME Gershwin, C Selmi, JM Anaya |
Journal of Autoimmunity | 2020 |
COVID‐19, varying genetic resistance to viral disease and immune tolerance checkpoints
CC Goodnow |
Immunology and Cell Biology | 2020 |
Mitigating Coronavirus Induced Dysfunctional Immunity for At-Risk Populations in COVID-19: Trained Immunity, BCG and “New Old Friends”
TO Kleen, AA Galdon, AS MacDonald, AG Dalgleish |
Frontiers in immunology | 2020 |
Part II. high-dose methotrexate with leucovorin rescue for severe COVID-19: An immune stabilization strategy for SARS-CoV-2 induced ‘PANIC’ attack
EM Frohman, NR Villemarette-Pittman, RA Cruz, R Longmuir, V Rowe, ES Rowe, TC Varkey, L Steinman, SS Zamvil, TC Frohman |
Journal of the Neurological Sciences | 2020 |
COVID-19 antibodies on trial
L DeFrancesco |
Nature Biotechnology | 2020 |
Mechanistic inferences from clinical reports of SARS-CoV-2
MM Jenkins, TR McCaw, PA Goepfert |
Infectious Diseases | 2020 |
High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects
X Liu, W Cao, T Li |
Frontiers in immunology | 2020 |
Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system
NM de Queiroz, FV Marinho, MA Chagas, LC Leite, EJ Homan, MT de Magalhães, SC Oliveira |
Microbes and infection / Institut Pasteur | 2020 |
The role of IgG Fc receptors in antibody-dependent enhancement
S Bournazos, A Gupta, JV Ravetch |
Nature Reviews Immunology | 2020 |
Merits and culprits of immunotherapies for neurological diseases in times of COVID-19
M Pawlitzki, UK Zettl, T Ruck, L Rolfes, HP Hartung, SG Meuth |
EBioMedicine | 2020 |
Mechanisms of Dysregulated Humoral and Cellular Immunity by SARS-CoV-2
N Taefehshokr, S Taefehshokr, B Heit |
Pathogens | 2020 |
Identification of a metabolic gene panel to predict the prognosis of myelodysplastic syndrome
F Hu, S Chen, Y Dai, Y Wang, Z Qin, H Li, L Shu, J Li, H Huang, Y Liang |
Journal of Cellular and Molecular Medicine | 2020 |
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
M Merad, JC Martin |
Nature Reviews Immunology | 2020 |
Immunometabolic Status of COVID-19 Cancer Patients
A Sica, MP Colombo, A Trama, L Horn, MC Garassino, V Torri |
Physiological reviews | 2020 |
The trinity of COVID-19: immunity, inflammation and intervention
MZ Tay, CM Poh, L Rénia, PA MacAry, LF Ng |
Nature Reviews Immunology | 2020 |
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
A Grifoni, D Weiskopf, SI Ramirez, J Mateus, JM Dan, CR Moderbacher, SA Rawlings, A Sutherland, L Premkumar, RS Jadi, D Marrama, AM de Silva, A Frazier, AF Carlin, JA Greenbaum, B Peters, F Krammer, DM Smith, S Crotty, A Sette |
Cell | 2020 |
Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges
M Hajivalili, M Hosseini, M Haji-Fatahaliha |
Life Sciences | 2020 |
Lessons for COVID-19 Immunity from Other Coronavirus Infections
A Sariol, S Perlman |
Immunity | 2020 |
Immune responses during COVID-19 infection
C Melenotte, A Silvin, AG Goubet, I Lahmar, A Dubuisson, A Zumla, D Raoult, M Merad, B Gachot, C Hénon, E Solary, M Fontenay, F André, M Maeurer, G Ippolito, M Piacentini, FS Wang, F Ginhoux, A Marabelle, G Kroemer, L Derosa, L Zitvogel |
OncoImmunology | 2020 |
The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
Y Zhang, B Li, B Ning |
Frontiers in immunology | 2020 |
Immunology of COVID‐19: Mechanisms, clinical outcome, diagnostics, and perspectives—A report of the European Academy of Allergy and Clinical Immunology (EAACI)
M Sokolowska, ZM Lukasik, I Agache, CA Akdis, D Akdis, M Akdis, W Barcik, HA Brough, T Eiwegger, A Eljaszewicz, S Eyerich, W Feleszko, C GomezCasado, K HoffmannSommergruber, J Janda, R JiménezSaiz, M Jutel, EF Knol, IK Krohn, A Kothari, J Makowska, M Moniuszko, H Morita, L O'Mahony, K Nadeau, C Ozdemir, I PaliSchöll, O Palomares, F Papaleo, M Prunicki, CB SchmidtWeber, A Sediva, J Schwarze, MH Shamji, GA TramperStranders, W Veen, E Untersmayr |
Allergy | 2020 |
Immunology of COVID‐19 and disease‐modifying therapies: the good, the bad and the unknown
T Zrzavy, I Wimmer, PS Rommer, T Berger |
European journal of neurology : the official journal of the European Federation of Neurological Societies | 2020 |
Facing SARS-CoV-2 outbreak in immunotherapy era
F Citarella, M Russano, F Pantano, E Dell'Aquila, B Vincenzi, G Tonini, D Santini |
Future Oncology | 2020 |
Nanotechnology for COVID-19: Therapeutics and Vaccine Research
G Chauhan, MJ Madou, S Kalra, V Chopra, D Ghosh, SO Martinez-Chapa |
ACS Nano | 2020 |
The potential danger of suboptimal antibody responses in COVID-19
A Iwasaki, Y Yang |
Nature Reviews Immunology | 2020 |
Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity
SN Amrun, CY Lee, B Lee, SW Fong, BE Young, RS Chee, NK Yeo, A Torres-Ruesta, G Carissimo, CM Poh, ZW Chang, MZ Tay, YH Chan, MI Chen, JG Low, PA Tambyah, S Kalimuddin, S Pada, SY Tan, LJ Sun, YS Leo, DC Lye, L Renia, LF Ng |
EBioMedicine | 2020 |
The lethal sex gap: COVID-19
EJ Márquez, J Trowbridge, GA Kuchel, J Banchereau, D Ucar |
Immunity & Ageing | 2020 |
Immune asynchrony in COVID-19 pathogenesis and potential immunotherapies
T Zhou, TT Su, T Mudianto, J Wang |
Journal of Experimental Medicine | 2020 |
Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses
R Zhou, KK To, YC Wong, L Liu, B Zhou, X Li, H Huang, Y Mo, TY Luk, TT Lau, P Yeung, WM Chan, AK Wu, KC Lung, OT Tsang, WS Leung, IF Hung, KY Yuen, Z Chen |
Immunity | 2020 |
Implications of COVID-19 in pediatric rheumatology
ED Batu, S Özen |
Rheumatology International | 2020 |
Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development
R de Alwis, S Chen, ES Gan, EE Ooi |
EBioMedicine | 2020 |
Immunology of COVID-19: Current State of the Science
N Vabret, GJ Britton, C Gruber, S Hegde, J Kim, M Kuksin, R Levantovsky, L Malle, A Moreira, MD Park, L Pia, E Risson, M Saffern, B Salomé, ME Selvan, MP Spindler, J Tan, V van der Heide, JK Gregory, K Alexandropoulos, N Bhardwaj, BD Brown, B Greenbaum, ZH Gümüş, D Homann, A Horowitz, AO Kamphorst, MA de Lafaille, S Mehandru, M Merad, RM Samstein, M Agrawal, M Aleynick, M Belabed, M Brown, M Casanova-Acebes, J Catalan, M Centa, A Charap, A Chan, ST Chen, J Chung, CC Bozkus, E Cody, F Cossarini, E Dalla, N Fernandez, J Grout, DF Ruan, P Hamon, E Humblin, D Jha, J Kodysh, A Leader, M Lin, K Lindblad, D Lozano-Ojalvo, G Lubitz, A Magen, Z Mahmood, G Martinez-Delgado, J Mateus-Tique, E Meritt, C Moon, J Noel, T ODonnell, M Ota, T Plitt, V Pothula, J Redes, IR Torres, M Roberto, AR Sanchez-Paulete, J Shang, AS Schanoski, M Suprun, M Tran, N Vaninov, CM Wilk, J Aguirre-Ghiso, D Bogunovic, J Cho, J Faith, E Grasset, P Heeger, E Kenigsberg, F Krammer, U Laserson |
Immunity | 2020 |
Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools
Y Fu, Y Cheng, Y Wu |
Virologica Sinica | 2020 |
The Potential Role of Th17 Immune Responses in Coronavirus Immunopathology and Vaccine-induced Immune Enhancement
PJ Hotez, ME Bottazzi, DB Corry |
Microbes and infection / Institut Pasteur | 2020 |
Animal models for emerging coronavirus: progress and new insights
L Yuan, Q Tang, T Cheng, N Xia |
Emerging Microbes & Infections | 2020 |
Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial
PM Folegatti, M Bittaye, A Flaxman, FR Lopez, D Bellamy, A Kupke, C Mair, R Makinson, J Sheridan, C Rohde, S Halwe, Y Jeong, YS Park, JO Kim, M Song, A Boyd, N Tran, D Silman, I Poulton, M Datoo, J Marshall, Y Themistocleous, A Lawrie, R Roberts, E Berrie, S Becker, T Lambe, A Hill, K Ewer, S Gilbert |
The Lancet Infectious Diseases | 2020 |
Promise and challenges in the development of COVID-19 vaccines
W Chen |
Human Vaccines & Immunotherapeutics | 2020 |
Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19
S Lega, S Naviglio, S Volpi, A Tommasini |
Human vaccines | 2020 |
COVID-19 Vaccines: “Warp Speed” Needs Mind Melds, Not Warped Minds
JP Moore, PJ Klasse, G Silvestri |
Journal of virology | 2020 |
An effective CTL peptide vaccine for Ebola Zaire Based on Survivors’ CD8+ targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design
CV Herst, S Burkholz, J Sidney, A Sette, PE Harris, S Massey, T Brasel, E Cunha-Neto, DS Rosa, WC Chao, R Carback, T Hodge, L Wang, S Ciotlos, P Lloyd, R Rubsamen |
Vaccine | 2020 |
Immunotherapeutic approaches to curtail COVID-19
H Owji, M Negahdaripour, N Hajighahramani |
International Immunopharmacology | 2020 |
COVID-19 in a Severely Immunosuppressed Patient With Life-Threatening Eosinophilic Granulomatosis With Polyangiitis
MA Schramm, N Venhoff, D Wagner, J Thiel, D Huzly, N Craig-Mueller, M Panning, H Hengel, WV Kern, RE Voll |
Frontiers in immunology | 2020 |
Serodiagnostics for Severe Acute Respiratory Syndrome–Related Coronavirus 2: A Narrative Review
MP Cheng, CP Yansouni, NE Basta, M Desjardins, S Kanjilal, K Paquette, C Caya, M Semret, C Quach, M Libman, L Mazzola, JA Sacks, S Dittrich, J Papenburg |
Annals of internal medicine | 2020 |
Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients
P Bost, A Giladi, Y Liu, Y Bendjelal, G Xu, E David, R Blecher-Gonen, M Cohen, C Medaglia, H Li, A Deczkowska, S Zhang, B Schwikowski, Z Zhang, I Amit |
Cell | 2020 |
Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19
B Zhang, X Zhou, C Zhu, Y Song, F Feng, Y Qiu, J Feng, Q Jia, Q Song, B Zhu, J Wang |
Frontiers in Molecular Biosciences | 2020 |
Anti-SARS-CoV-2 hyperimmune plasma workflow
P Annamaria, Q Eugenia, S Paolo |
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2020 |
Potential role of interferons in treating COVID-19 patients
MH Abdolvahab, S Moradi-kalbolandi, M Zarei, D Bose, K Majidzadeh-A, L Farahmand |
International Immunopharmacology | 2020 |
Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis
L Wang, Y Shen, M Li, H Chuang, Y Ye, H Zhao, H Wang |
Journal of Neurology | 2020 |
An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques
L Feng, Q Wang, C Shan, C Yang, Y Feng, J Wu, X Liu, Y Zhou, R Jiang, P Hu, X Liu, F Zhang, P Li, X Niu, Y Liu, X Zheng, J Luo, J Sun, Y Gu, B Liu, Y Xu, C Li, W Pan, J Zhao, C Ke, X Chen, T Xu, N Zhong, S Guan, Z Yuan, L Chen |
Nature Communications | 2020 |
Recovery from COVID-19 in a B-cell-depleted multiple sclerosis patient
H Wurm, K Attfield, AK Iversen, R Gold, L Fugger, A Haghikia |
Multiple sclerosis (Houndmills, Basingstoke, England) | 2020 |
Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses
X Ma, F Zou, F Yu, R Li, Y Yuan, Y Zhang, X Zhang, J Deng, T Chen, Z Song, Y Qiao, Y Zhan, J Liu, J Zhang, X Zhang, Z Peng, Y Li, Y Lin, L Liang, G Wang, Y Chen, Q Chen, T Pan, X He, H Zhang |
Immunity | 2020 |
Humoral Responses and Serological Assays in SARS-CoV-2 Infections
Y Galipeau, M Greig, G Liu, M Driedger, MA Langlois |
Frontiers in immunology | 2020 |
Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development?
L Lu, H Zhang, M Zhan, J Jiang, H Yin, DJ Dauphars, SY Li, Y Li, YW He |
Science China Life Sciences | 2020 |
COVID-19-neutralizing antibodies predict disease severity and survival
WF Garcia-Beltran, EC Lam, MG Astudillo, D Yang, TE Miller, J Feldman, BM Hauser, TM Caradonna, KL Clayton, AD Nitido, MR Murali, G Alter, RC Charles, A Dighe, JA Branda, JK Lennerz, D Lingwood, AG Schmidt, AJ Iafrate, AB Balazs |
Cell | 2020 |
SARS-CoV-2 mediated lung inflammatory responses in host: targeting the cytokine storm for therapeutic interventions
P Asrani, I Hassan |
Molecular and Cellular Biochemistry | 2020 |
COVID-19: The Emerging Immunopathological Determinants for Recovery or Death
T Ahmad, R Chaudhuri, MC Joshi, A Almatroudi, AH Rahmani, SM Ali |
Frontiers in microbiology | 2020 |
Pathophysiology and potential future therapeutic targets using preclinical models of COVID-19
R Kumar, MH Lee, C Mickael, B Kassa, Q Pasha, R Tuder, B Graham |
ERJ Open Research | 2020 |
Monocyte activation in systemic Covid-19 infection: Assay and rationale
FO Martinez, TW Combes, F Orsenigo, S Gordon |
EBioMedicine | 2020 |
A Thermostable mRNA Vaccine against COVID-19
NN Zhang, XF Li, YQ Deng, H Zhao, YJ Huang, G Yang, WJ Huang, P Gao, C Zhou, RR Zhang, Y Guo, SH Sun, H Fan, SL Zu, Q Chen, Q He, TS Cao, XY Huang, HY Qiu, JH Nie, Y Jiang, HY Yan, Q Ye, X Zhong, XL Xue, ZY Zha, D Zhou, X Yang, YC Wang, B Ying, CF Qin |
Cell | 2020 |
COVID-19: Coronavirus Vaccine Development Updates
J Zhao, S Zhao, J Ou, J Zhang, W Lan, W Guan, X Wu, Y Yan, W Zhao, J Wu, J Chodosh, Q Zhang |
Frontiers in immunology | 2020 |
Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients
JC Holter, SE Pischke, E de Boer, A Lind, S Jenum, AR Holten, K Tonby, A Barratt-Due, M Sokolova, C Schjalm, V Chaban, A Kolderup, T Tran, TT Gjølberg, LG Skeie, L Hesstvedt, V Ormåsen, B Fevang, C Austad, KE Müller, C Fladeby, M Holberg-Petersen, B Halvorsen, F Müller, P Aukrust, S Dudman, T Ueland, JT Andersen, F Lund-Johansen, L Heggelund, AM Dyrhol-Riise, TE Mollnes |
Proceedings of the National Academy of Sciences | 2020 |
Therapeutic modalities and novel approaches in regenerative medicine for COVID-19
R Ramezankhani, R Solhi, A Memarnejadian, F Nami, SM Hashemian, T Tricot, M Vosough, C Verfaillie |
International Journal of Antimicrobial Agents | 2020 |
Dissecting antibody-mediated protection against SARS-CoV-2
T Zohar, G Alter |
Nature Reviews Immunology | 2020 |
Does SARS-CoV-2 Trigger Stress-Induced Autoimmunity by Molecular Mimicry? A Hypothesis
F Cappello, AM Gammazza, F Dieli, EC de Macario, AJ Macario |
Journal of Clinical Medicine | 2020 |
Blood Banking and Transfusion Medicine Challenges During the COVID-19 Pandemic
A Ngo, D Masel, C Cahill, N Blumberg, MA Refaai |
Clinics in Laboratory Medicine | 2020 |
Cellular and Molecular Pathways of COVID-19 and Potential Points of Therapeutic Intervention
JP Hussman |
Frontiers in pharmacology | 2020 |
Convalescent Plasma: The Relay Baton in the Race for Coronavirus Disease 2019 Treatment
J Ouyang, S Isnard, J Lin, B Fombuena, X Peng, JP Routy, Y Chen |
Frontiers in immunology | 2020 |
Convalescent Plasma against COVID-19: A Broad-Spectrum Therapeutic Approach for Emerging Infectious Diseases
M Thijssen, T Devos, HS Ejtahed, S Amini-Bavil-Olyaee, AA Pourfathollah, MR Pourkarim |
Microorganisms | 2020 |
Antibody-dependent enhancement and COVID-19: Moving toward acquittal
EJ Yager |
Clinical Immunology | 2020 |
The role of host genetics in the immune response to SARS‐CoV‐2 and COVID‐19 susceptibility and severity
IG Ovsyannikova, IH Haralambieva, SN Crooke, GA Poland, RB Kennedy |
Immunological Reviews | 2020 |
COVID-19: Immunology and treatment options
S Felsenstein, JA Herbert, PS McNamara, CM Hedrich |
Clinical Immunology | 2020 |
In vivo expressed biologics for infectious disease prophylaxis: rapid delivery of DNA-based antiviral antibodies
CD Andrews, Y Huang, DD Ho, RA Liberatore |
Emerging Microbes & Infections | 2020 |
Immunological considerations for COVID-19 vaccine strategies
M Jeyanathan, S Afkhami, F Smaill, MS Miller, BD Lichty, Z Xing |
Nature Reviews Immunology | 2020 |
Pandemic Preparedness: Developing Vaccines and Therapeutic Antibodies For COVID-19
GD Sempowski, KO Saunders, P Acharya, KJ Wiehe, BF Haynes |
Cell | 2020 |
Convalescent plasma to treat critically ill patients with COVID-19: framing the need for randomised clinical trials
M Shankar-Hari, L Estcourt, H Harvala, D Roberts, DK Menon, M Shankar-Hari, L Estcourt, H Harvala, D Roberts, DK Menon |
Critical Care | 2020 |
Is Cross-Reactive Immunity Triggering COVID-19 Immunopathogenesis?
A Beretta, M Cranage, D Zipeto |
Frontiers in immunology | 2020 |
Vaccination against SARS-CoV-2 and disease enhancement – knowns and unknowns
RM Zellweger, TA Wartel, F Marks, M Song, JH Kim |
Expert Review of Vaccines | 2020 |
New Insights of Emerging SARS-CoV-2: Epidemiology, Etiology, Clinical Features, Clinical Treatment, and Prevention
G Guo, L Ye, K Pan, Y Chen, D Xing, K Yan, Z Chen, N Ding, W Li, H Huang, L Zhang, X Li, X Xue |
Frontiers in Cell and Developmental Biology | 2020 |
Biomaterials-Based Opportunities to Engineer the Pulmonary Host Immune Response in COVID-19
BM Jarai, Z Stillman, K Bomb, AM Kloxin, CA Fromen |
ACS Biomaterials Science & Engineering | 2020 |
Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19
RP Saha, AR Sharma, MK Singh, S Samanta, S Bhakta, S Mandal, M Bhattacharya, SS Lee, C Chakraborty |
Frontiers in pharmacology | 2020 |
Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization
PJ Klasse, JP Moore |
eLife | 2020 |
Coronavirus disease 2019 (COVID‐19): An overview of the immunopathology, serological diagnosis and management
AU Anka, MI Tahir, SD Abubakar, M Alsabbagh, Z Zian, H Hamedifar, A Sabzevari, G Azizi |
Scandinavian Journal of Immunology | 2020 |
Severe COVID-19: what have we learned with the immunopathogenesis?
B Bordallo, M Bellas, AF Cortez, M Vieira, M Pinheiro |
2020 | |
SARS-CoV-2 Treatment Approaches: Numerous Options, No Certainty for a Versatile Virus
S Iacob, DG Iacob |
Frontiers in pharmacology | 2020 |
The four horsemen of a viral Apocalypse: The pathogenesis of SARS-CoV-2 infection (COVID-19)
P Domingo, I Mur, V Pomar, H Corominas, J Casademont, N de Benito |
EBioMedicine | 2020 |
Immune Response to COVID-19: Can We Benefit from the SARS-CoV and MERS-CoV Pandemic Experience?
E Sinderewicz, W Czelejewska, K Jezierska-Wozniak, J Staszkiewicz-Chodor, W Maksymowicz |
Pathogens | 2020 |
COVID‐19 and immunological regulations – from basic and translational aspects to clinical implications
MP Schön, C Berking, T Biedermann, T Buhl, L Erpenbeck, K Eyerich, S Eyerich, K Ghoreschi, M Goebeler, RJ Ludwig, K Schäkel, B Schilling, C Schlapbach, G Stary, E Stebut, K Steinbrink |
Journal der Deutschen Dermatologischen Gesellschaft | 2020 |
COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies
A Rauf, T Abu-Izneid, A Olatunde, AA Khalil, FA Alhumaydhi, T Tufail, MA Shariati, M Rebezov, ZM Almarhoon, YN Mabkhot, A Alsayari, KR Rengasamy |
International journal of environmental research and public health | 2020 |
Severe acute respiratory syndrome‐coronavirus‐2 spike (S) protein based vaccine candidates: State of the art and future prospects
A Arashkia, S Jalilvand, N Mohajel, A Afchangi, K Azadmanesh, M SalehiVaziri, M Fazlalipour, MH Pouriayevali, T Jalali, SD Nasab, F Roohvand, Z Shoja |
Reviews in Medical Virology | 2020 |
The underpinning biology relating to multiple sclerosis disease modifying treatments during the COVID-19 pandemic
D Baker, S Amor, AS Kang, K Schmierer, G Giovannoni |
Multiple Sclerosis and Related Disorders | 2020 |
Human post‐infection serological response to the spike and nucleocapsid proteins of SARS‐CoV‐2
C Xiao, S Ling, M Qiu, Z Deng, L Chen, A Zhu, Y Chen, Y Liu, X Lin, F Lin, Q Wu, L Shen, F Ye, X Liu, Y Li, J Zhao, Z Yang, BJ Cowling, R Webby, M Zanin, SS Wong |
Influenza and Other Respiratory Viruses | 2020 |
A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2
AO Hassan, NM Kafai, IP Dmitriev, JM Fox, BK Smith, IB Harvey, RE Chen, ES Winkler, AW Wessel, JB Case, E Kashentseva, BT McCune, AL Bailey, H Zhao, LA VanBlargan, YN Dai, M Ma, LJ Adams, S Shrihari, JE Danis, LE Gralinski, YJ Hou, A Schäfer, AS Kim, SP Keeler, D Weiskopf, RS Baric, MJ Holtzman, DH Fremont, DT Curiel, MS Diamond |
Cell | 2020 |
STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters
R Boudewijns, HJ Thibaut, SJ Kaptein, R Li, V Vergote, L Seldeslachts, JV Weyenbergh, CD Keyzer, L Bervoets, S Sharma, L Liesenborghs, J Ma, S Jansen, DV Looveren, T Vercruysse, X Wang, D Jochmans, E Martens, K Roose, DD Vlieger, B Schepens, TV Buyten, S Jacobs, Y Liu, J Martí-Carreras, B Vanmechelen, T Wawina-Bokalanga, L Delang, J Rocha-Pereira, L Coelmont, W Chiu, P Leyssen, E Heylen, D Schols, L Wang, L Close, J Matthijnssens, MV Ranst, V Compernolle, G Schramm, KV Laere, X Saelens, N Callewaert, G Opdenakker, P Maes, B Weynand, C Cawthorne, GV Velde, Z Wang, J Neyts, K Dallmeier |
Nature Communications | 2020 |
Principles Learned from the International Race to Develop a Safe and Effective COVID-19 Vaccine
AH Thames, KL Wolniak, SI Stupp, MC Jewett |
ACS Central Science | 2020 |
Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report
MS Buckland, JB Galloway, CN Fhogartaigh, L Meredith, NM Provine, S Bloor, A Ogbe, WM Zelek, A Smielewska, A Yakovleva, T Mann, L Bergamaschi, L Turner, F Mescia, EJ Toonen, CP Hackstein, HD Akther, VA Vieira, L Ceron-Gutierrez, J Periselneris, S Kiani-Alikhan, S Grigoriadou, D Vaghela, SE Lear, ME Török, WL Hamilton, J Stockton, J Quick, P Nelson, M Hunter, TI Coulter, L Devlin, JR Bradley, KG Smith, WH Ouwehand, L Estcourt, H Harvala, DJ Roberts, IB Wilkinson, N Screaton, N Loman, R Doffinger, PA Lyons, BP Morgan, IG Goodfellow, P Klenerman, PJ Lehner, NJ Matheson, JE Thaventhiran |
Nature Communications | 2020 |
Significant Unresolved Questions and Opportunities for Bioengineering in Understanding and Treating COVID-19 Disease Progression
J Shirazi, MJ Donzanti, KM Nelson, R Zurakowski, CA Fromen, JP Gleghorn |
Cellular and Molecular Bioengineering | 2020 |
Artificial intelligence predicts the immunogenic landscape of SARS-CoV-2 leading to universal blueprints for vaccine designs
B Malone, B Simovski, C Moliné, J Cheng, M Gheorghe, H Fontenelle, I Vardaxis, S Tennøe, JA Malmberg, R Stratford, T Clancy |
Scientific Reports | 2020 |
A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction
M Ejemel, Q Li, S Hou, ZA Schiller, JA Tree, A Wallace, A Amcheslavsky, NK Yilmaz, KR Buttigieg, MJ Elmore, K Godwin, N Coombes, JR Toomey, R Schneider, AS Ramchetty, BJ Close, DY Chen, HL Conway, M Saeed, C Ganesa, MW Carroll, LA Cavacini, MS Klempner, CA Schiffer, Y Wang |
Nature Communications | 2020 |
Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development
SK Samrat, AM Tharappel, Z Li, H Li |
Virus Research | 2020 |
As Plain as the Nose on Your Face: The Case for A Nasal (Mucosal) Route of Vaccine Administration for Covid-19 Disease Prevention
CR Travis |
Frontiers in immunology | 2020 |
Antibody Response to Severe Acute Respiratory Syndrome‐ Corona Virus 2, Diagnostic and Therapeutic Implications
Y Ishay, A Kessler, A Schwarts, Y Ilan |
Hepatology Communications | 2020 |
Learning from the past: development of safe and effective COVID-19 vaccines
S Su, L Du, S Jiang |
Nature Reviews Microbiology | 2020 |
On the genetics and immunopathogenesis of COVID-19
CO Jacob |
Clinical Immunology | 2020 |
Dysregulation of type I interferon responses in COVID-19
D Acharya, GQ Liu, MU Gack |
Nature Reviews Immunology | 2020 |
COVID‐19 und Immunregulation – von grundlegenden und translationalen Aspekten zu klinischen Implikationen
MP Schön, C Berking, T Biedermann, T Buhl, L Erpenbeck, K Eyerich, S Eyerich, K Ghoreschi, M Goebeler, RJ Ludwig, K Schäkel, B Schilling, C Schlapbach, G Stary, E Stebut, K Steinbrink |
Journal der Deutschen Dermatologischen Gesellschaft | 2020 |
Cytokine storm induced by SARS-CoV-2
P Song, W Li, J Xie, Y Hou, C You |
Clinica chimica acta; international journal of clinical chemistry | 2020 |
Clinical predictors of donor antibody titre and correlation with recipient antibody response in a COVID‐19 convalescent plasma clinical trial
ML Madariaga, JJ Guthmiller, S Schrantz, MO Jansen, C Christensen, M Kumar, M Prochaska, G Wool, A DurkinCelauro, WH Oh, L Trockman, J Vigneswaran, R Keskey, DG Shaw, H Dugan, NY Zheng, M Cobb, H Utset, J Wang, O Stovicek, C Bethel, S Matushek, M Giurcanu, KG Beavis, D Sabato, D Meltzer, MK Ferguson, JP Kress, K Shanmugarajah, JB Matthews, JF Fung, PC Wilson, JC Alverdy, JS Donington |
Journal of Internal Medicine | 2020 |
Active Therapy with Passive Immunotherapy May Be Effective in the Fight against COVID‐19
CJ Morabito, B Gangadharan |
Clinical and Translational Science | 2020 |
The role of SARS‐CoV ‐2 antibodies in COVID ‐19: Healing in most, harm at times
MA French, Y Moodley |
Respirology (Carlton, Vic.) | 2020 |
SARS-CoV-2/COVID-19: Evolving Reality, Global Response, Knowledge Gaps, and Opportunities
MF Osuchowski, F Aletti, JM Cavaillon, SB Flohé, EJ Giamarellos-Bourboulis, M Huber-Lang, B Relja, T Skirecki, A Szabó, M Maegele |
Shock | 2020 |
ADE and hyperinflammation in SARS-CoV2 infection- comparison with dengue hemorrhagic fever and feline infectious peritonitis
M Cloutier, M Nandi, AU Ihsan, HA Chamard, S Ilangumaran, S Ramanathan |
Cytokine | 2020 |
Consensus Summary Report for CEPI/BC March 12-13, 2020 Meeting: Assessment of Risk of Disease Enhancement with COVID-19 Vaccines
PH Lambert, DM Ambrosino, SR Andersen, RS Baric, SB Black, RT Chen, CL Dekker, AM Didierlaurent, BS Graham, SD Martin, DC Molrine, S Perlman, PA Picard-Fraser, AJ Pollard, C Qin, K Subbarao, JP Cramer |
Vaccine | 2020 |
Viral targets for vaccines against COVID-19
L Dai, GF Gao |
Nature Reviews Immunology | 2020 |
Sustained Responses of Neutralizing Antibodies Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Recovered Patients and Their Therapeutic Applicability
YS Kim, A Aigerim, U Park, Y Kim, H Park, JY Rhee, JP Choi, WB Park, SW Park, Y Kim, DG Lim, JY Choi, YK Jeon, JS Yang, JY Lee, HS Shin, NH Cho |
Clinical Infectious Diseases | 2020 |
What are the roles of antibodies versus a durable, high quality T-cell response in protective immunity against SARS-CoV-2?
M Hellerstein |
2020 | |
Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies
PM Varghese, AG Tsolaki, H Yasmin, A Shastri, J Ferluga, M Vatish, T Madan, U Kishore |
Immunobiology | 2020 |
Convalescent plasma therapy for coronavirus infection: experience from MERS and application in COVID-19
JA Al-Tawfiq, Y Arabi |
Human Vaccines & Immunotherapeutics | 2020 |
Immunity, endothelial injury and complement-induced coagulopathy in COVID-19
L Perico, A Benigni, F Casiraghi, LF Ng, L Renia, G Remuzzi |
Nature Reviews Nephrology | 2020 |
Severe COVID-19 and aging: are monocytes the key?
Pence BD |
GeroScience | 2020 |
ACE2 at the centre of COVID-19 from paucisymptomatic infections to severe pneumonia
Rivellese F, Prediletto E |
Autoimmunity Reviews | 2020 |
A Testimony of the Surgent SARS-CoV-2 in the Immunological Panorama of the Human Host
Minakshi R, Jan AT, Rahman S, Kim J |
Frontiers in Cellular and Infection Microbiology | 2020 |
COVID-19 and lung cancer: risks, mechanisms and treatment interactions.
Addeo A, Obeid M, Friedlaender A |
Journal for ImmunoTherapy of Cancer | 2020 |
Next-Generation Sequencing of T and B Cell Receptor Repertoires from COVID-19 Patients Showed Signatures Associated with Severity of Disease.
Schultheiß C, Paschold L, Simnica D, Mohme M, Willscher E, von Wenserski L, Scholz R, Wieters I, Dahlke C, Tolosa E, Sedding DG, Ciesek S, Addo M, Binder M |
Immunity | 2020 |
Cancer and COVID-19: Unmasking their ties.
Addeo A, Friedlaender A |
Cancer Treatment Reviews | 2020 |
Mechanisms of SARS-CoV-2 Transmission and Pathogenesis.
Harrison AG, Lin T, Wang P |
Trends in Immunology | 2020 |
Fostamatinib Inhibits Neutrophils Extracellular Traps Induced by COVID-19 Patient Plasma: A Potential Therapeutic
Strich JR, Ramos-Benitez MJ, Randazzo D, Stein SR, Babyak A, Davey RT, Suffredini AF, Childs RW, Chertow DS |
The Journal of Infectious Diseases | 2020 |
SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates.
Poland GA, Ovsyannikova IG, Kennedy RB |
2020 | |
Prospects for mucosal vaccine: shutting the door on SARS-CoV-2.
Mudgal R, Nehul S, Tomar S |
Human Vaccines & Immunotherapeutics | 2020 |
Risiken und Chancen von Immuntherapien in Zeiten der Coronavirus-2019-Pandemie
Pawlitzki M, Zettl UK, Ruck T, Rolfes L, Hartung HP, Meuth SG |
2020 | |
High neutralizing antibody titer in intensive care unit patients with COVID-19
Liu L, To KK, Chan KH, Wong YC, Zhou R, Kwan KY, Fong CH, Chen LL, Choi CY, Lu L, Tsang OT, Leung WS, To WK, Hung IF, Yuen KY, Chen Z |
Emerging Microbes & Infections | 2020 |
Rekonvaleszentenplasma zur Behandlung von schwerem COVID-19: Rationale und Design einer randomisierten, offenen klinischen Studie von Rekonvaleszentenplasma verglichen mit bestmöglicher supportiver Behandlung (CAPSID-Studie)
Körper S, Jahrsdörfer B, Appl T, Klüter H, Seifried E, Schrezenmeier H |
2020 | |
Harnessing Recent Advances in Synthetic DNA and Electroporation Technologies for Rapid Vaccine Development Against COVID-19 and Other Emerging Infectious Diseases
Xu Z, Patel A, Tursi NJ, Zhu X, Muthumani K, Kulp DW, Weiner DB |
2020 | |
Immunoregulation with mTOR inhibitors to prevent COVID-19 severity: A novel intervention strategy beyond vaccines and specific antiviral medicines.
Zheng Y, Li R, Liu S |
Journal of Medical Virology | 2020 |
Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome.
Bouadma L, Wiedemann A, Patrier J, Surénaud M, Wicky PH, Foucat E, Diehl JL, Hejblum BP, Sinnah F, de Montmollin E, Lacabaratz C, Thiébaut R, Timsit JF, Lévy Y |
Journal of Clinical Immunology | 2020 |
Fruitful Neutralizing Antibody Pipeline Brings Hope To Defeat SARS-Cov-2.
Renn A, Fu Y, Hu X, Hall MD, Simeonov A |
Trends in Pharmacological Sciences | 2020 |
Anti-IL6R role in treatment of COVID-19-related ARDS
Buonaguro FM, Puzanov I, Ascierto PA |
Journal of Translational Medicine | 2020 |
Covid‐19 and dengue: Double punches for dengue‐endemic countries in Asia
Harapan H, Ryan M, Yohan B, Abidin RS, Nainu F, Rakib A, Jahan I, Emran TB, Ullah I, Panta K, Dhama K, Sasmono RT |
Reviews in Medical Virology | 2020 |
Susceptibility of the Elderly to SARS-CoV-2 Infection: ACE-2 Overexpression, Shedding, and Antibody-dependent Enhancement (ADE)
Peron JP, Nakaya H |
Clinics | 2020 |
Employing drug delivery strategies to create safe and effective pharmaceuticals for COVID‐19
McHugh KJ |
Bioengineering & Translational Medicine | 2020 |
Progress and Concept for COVID‐19 Vaccine Development
Wu S |
Biotechnology Journal | 2020 |
Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients
Yu HQ, Sun BQ, Fang ZF, Zhao JC, Liu XY, Li YM, Sun XZ, Liang HF, Zhong B, Huang ZF, Zheng PY, Tian LF, Qu HQ, Liu DC, Wang EY, Xiao XJ, Li SY, Ye F, Guan L, Hu DS, Hakonarson H, Liu ZG, Zhong NS |
European Respiratory Journal | 2020 |
Balancing Expediency and Scientific Rigor in Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development
Graepel KW, Kochhar S, Clayton EW, Edwards KE |
The Journal of Infectious Diseases | 2020 |
ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques
van Doremalen N, Lambe T, Spencer A, Belij-Rammerstorfer S, Purushotham JN, Port JR, Avanzato V, Bushmaker T, Flaxman A, Ulaszewska M, Feldmann F, Allen ER, Sharpe H, Schulz J, Holbrook M, Okumura A, Meade-White K, Pérez-Pérez L, Bissett C, Gilbride C, Williamson BN, Rosenke R, Long D, Ishwarbhai A, Kailath R, Rose L, Morris S, Powers C, Lovaglio J, Hanley PW, Scott D, Saturday G, de Wit E, Gilbert SC, Munster VJ |
2020 | |
Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2
Anderson DE, Tan CW, Chia WN, Young BE, Linster M, Low JH, Tan YJ, Chen MI, Smith GJ, Leo YS, Lye DC, Wang LF |
Emerging Microbes & Infections | 2020 |
Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients
Yongchen Z, Shen H, Wang X, Shi X, Li Y, Yan J, Chen Y, Gu B |
Emerging Microbes & Infections | 2020 |
Humoral Immune Responses in COVID-19 Patients: A Window on the State of the Art
Siracusano G, Pastori C, Lopalco L |
Frontiers in immunology | 2020 |
DNA vaccine protection against SARS-CoV-2 in rhesus macaques
Yu J, Tostanoski LH, Peter L, Mercado NB, McMahan K, Mahrokhian SH, Nkolola JP, Liu J, Li Z, Chandrashekar A, Martinez DR, Loos C, Atyeo C, Fischinger S, Burke JS, Slein MD, Chen Y, Zuiani A, Lelis FJ, Travers M, Habibi S, Pessaint L, Van Ry A, Blade K, Brown R, Cook A, Finneyfrock B, Dodson A, Teow E, Velasco J, Zahn R, Wegmann F, Bondzie EA, Dagotto G, Gebre MS, He X, Jacob-Dolan C, Kirilova M, Kordana N, Lin Z, Maxfield LF, Nampanya F, Nityanandam R, Ventura JD, Wan H, Cai Y, Chen B, Schmidt AG, Wesemann DR, Baric RS, Alter G, Andersen H, Lewis MG, Barouch DH |
Science (New York, N.Y.) | 2020 |
Coronaviruses pandemics: Can neutralizing antibodies help?
Tong PB, Lin LY, Tran TH |
Life Sciences | 2020 |
Current global vaccine and drug efforts against COVID-19: Pros and cons of bypassing animal trials
Deb B, Shah H, Goel S |
Journal of Biosciences | 2020 |
Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2
Wu JL, Tseng WP, Lin CH, Lee TF, Chung MY, Huang CH, Chen SY, Hsueh PR, Chen SC |
Journal of Infection | 2020 |
Recent Understandings Toward Coronavirus Disease 2019 (COVID-19): From Bench to Bedside
Yu J, Chai P, Ge S, Fan X |
Frontiers in Cell and Developmental Biology | 2020 |
Immunoinformatics characterization of SARS-CoV-2 spike glycoprotein for prioritization of epitope based multivalent peptide vaccine
Ismail S, Ahmad S, Azam SS |
Journal of Molecular Liquids | 2020 |
Dengue Fever, COVID‐19 (SARS‐CoV‐2), and Antibody‐Dependent Enhancement (ADE): A Perspective
Ulrich H, Pillat MM, Tárnok A |
Cytometry Part A | 2020 |
Considerations on biologicals for patients with allergic disease in times of the COVID‐19 pandemic: An EAACI statement
Vultaggio A, Agache I, Akdis CA, Akdis M, Bavbek S, Bossios A, Bousquet J, Boyman O, Chaker AM, Chan S, Chatzipetrou A, Feleszko W, Firinu D, Jutel M, Kauppi P, Klimek L, Kolios A, Kothari A, Kowalski ML, Matucci A, Palomares O, Pfaar O, Rogala B, Untersmayr E, Eiwegger T |
Allergy | 2020 |
COVID-19 Diagnostics, Tools, and Prevention
Allam M, Cai S, Ganesh S, Venkatesan M, Doodhwala S, Song Z, Hu T, Kumar A, Heit J, Coskun AF |
Diagnostics | 2020 |
Childhood Multisystem Inflammatory Syndrome — A New Challenge in the Pandemic
Levin M |
The New England journal of medicine | 2020 |
Dysregulated adaptive immune response contributes to severe COVID-19
Yu K, He J, Wu Y, Xie B, Liu X, Wei B, Zhou H, Lin B, Zuo Z, Wen W, Xu W, Zou B, Wei L, Huang X, Zhou P |
Cell Research | 2020 |
The dynamic changes of serum IgM and IgG against SARS‐CoV‐2 in patients with COVID‐19
Zhou W, Xu X, Chang Z, Wang H, Zhong X, Tong X, Liu T, Li Y |
Journal of Medical Virology | 2020 |
SARS-CoV2 vaccines: Slow is fast
Green DR |
Science Advances | 2020 |
What Would Jenner and Pasteur Have Done About COVID-19 Coronavirus? The Urges of a Vaccinologist
Palatnik-de-Sousa CB |
Frontiers in immunology | 2020 |
Can Nuclear Imaging of Activated Macrophages with Folic Acid-Based Radiotracers Serve as a Prognostic Means to Identify COVID-19 Patients at Risk?
Müller C, Schibli R, Maurer B |
Pharmaceuticals | 2020 |
Rabies virus-based COVID-19 vaccine CORAVAX™ induces high levels of neutralizing antibodies against SARS-CoV-2
Kurup D, Wirblich C, Ramage H, Schnell MJ |
npj Vaccines | 2020 |
Change of Antigenic Determinants of SARS-CoV-2 Virus S-Protein as a Possible Cause of Antibody-Dependent Enhancement of Virus Infection and Cytokine Storm
Nechipurenko YD, Anashkina AA, Matveeva OV |
Biophysics | 2020 |
Coronavirus-2019 Disease (COVID-19) in Children
Ovali F |
2020 | |
Informed consent disclosure to vaccine trial subjects of risk of COVID‐19 vaccines worsening clinical disease
Cardozo T, Veazey R |
International Journal of Clinical Practice | 2020 |
Multisystem Inflammatory Syndrome in Children Related to COVID-19: the First Case in Korea
Kim H, Shim JY, Ko JH, Yang A, Shim JW, Kim DS, Jung HL, Kwak JH, Sol IS |
Journal of Korean Medical Science | 2020 |
Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients
Pierce CA, Preston-Hurlburt P, Dai Y, Aschner CB, Cheshenko N, Galen B, Garforth SJ, Herrera NG, Jangra RK, Morano NC, Orner E, Sy S, Chandran K, Dziura J, Almo SC, Ring A, Keller MJ, Herold KC, Herold BC |
Science Translational Medicine | 2020 |
Characterization of neutralizing antibody with prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus monkeys
Wang S, Peng Y, Wang R, Jiao S, Wang M, Huang W, Shan C, Jiang W, Li Z, Gu C, Chen B, Hu X, Yao Y, Min J, Zhang H, Chen Y, Gao G, Tang P, Li G, Wang A, Wang L, Zhang J, Chen S, Gui X, Yuan Z, Liu D |
Nature Communications | 2020 |
Drawing Comparisons between SARS-CoV-2 and the Animal Coronaviruses
Ghosh S, Malik YS |
Microorganisms | 2020 |
How to Survive COVID‐19 Even If the Vaccine Fails
Branch AD |
Hepatology Communications | 2020 |
Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19
Van Damme KF, Tavernier S, Van Roy N, De Leeuw E, Declercq J, Bosteels C, Maes B, De Bruyne M, Bogaert D, Bosteels V, Hoste L, Naesens L, Maes P, Grifoni A, Weiskopf D, Sette A, Depuydt P, Van Braeckel E, Haerynck F, Lambrecht BN |
Frontiers in immunology | 2020 |
Antibody responses in COVID-19 patients
Liu S, Lu S |
Journal of Biomedical Research | 2020 |
Potential roles of mitochondrial cofactors in the adjuvant mitigation of proinflammatory acute infections, as in the case of sepsis and COVID-19 pneumonia
Pagano G, Manfredi C, Pallardó FV, Lyakhovich A, Tiano L, Trifuoggi M |
Inflammation Research | 2020 |
Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2
Shahrajabian MH, Sun W, Cheng Q |
Human Vaccines & Immunotherapeutics | 2020 |
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
van Doremalen N, Lambe T, Spencer A, Belij-Rammerstorfer S, Purushotham JN, Port JR, Avanzato VA, Bushmaker T, Flaxman A, Ulaszewska M, Feldmann F, Allen ER, Sharpe H, Schulz J, Holbrook M, Okumura A, Meade-White K, Pérez-Pérez L, Edwards NJ, Wright D, Bissett C, Gilbride C, Williamson BN, Rosenke R, Long D, Ishwarbhai A, Kailath R, Rose L, Morris S, Powers C, Lovaglio J, Hanley PW, Scott D, Saturday G, de Wit E, Gilbert SC, Munster VJ |
Nature | 2020 |
COVID-19 - Recent advancements in identifying novel vaccine candidates and current status of upcoming SARS-CoV-2 vaccines
Iqbal Yatoo M, Hamid Z, Parray OR, Wani AH, Ul Haq A, Saxena A, Patel SK, Pathak M, Tiwari R, Malik YS, Sah R, Rabaan AA, Rodriguez Morales AJ, Dhama K |
Human Vaccines & Immunotherapeutics | 2020 |
Coronavirus disease 2019 (COVID-19) in domestic animals and wildlife: advances and prospects in the development of animal models for vaccine and therapeutic research
Sharun K, Tiwari R, Patel SK, Karthik K, Iqbal Yatoo M, Malik YS, Singh KP, Panwar PK, Harapan H, Singh RK, Dhama K |
Human Vaccines & Immunotherapeutics | 2020 |
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.
To KK, Tsang OT, Leung WS, Tam AR, Wu TC, Lung DC, Yip CC, Cai JP, Chan JM, Chik TS, Lau DP, Choi CY, Chen LL, Chan WM, Chan KH, Ip JD, Ng AC, Poon RW, Luo CT, Cheng VC, Chan JF, Hung IF, Chen Z, Chen H, Yuen KY |
The Lancet Infectious Diseases | 2020 |
Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2.
Zhou G, Zhao Q |
International journal of biological sciences | 2020 |
Progress and Prospects on Vaccine Development against SARS-CoV-2.
Zhang J, Zeng H, Gu J, Li H, Zheng L, Zou Q |
Human vaccines | 2020 |
Hyperglycemia, hydroxychloroquine, and the COVID-19 pandemic.
Brufsky A |
Journal of Medical Virology | 2020 |
Therapeutic opportunities to manage COVID-19/SARS-CoV-2 infection: Present and future.
Shetty R, Ghosh A, Honavar SG, Khamar P, Sethu S |
Indian journal of ophthalmology | 2020 |
A strategy targeting monocyte-macrophage differentiation to avoid pulmonary complications in SARS-Cov2 infection.
Gómez-Rial J, Martinón-Torres F |
Clinical Immunology | 2020 |
COVID-19 diagnosis and management: a comprehensive review.
Pascarella G, Strumia A, Piliego C, Bruno F, Del Buono R, Costa F, Scarlata S, Agrò FE |
Journal of Internal Medicine | 2020 |
COVID-19 Convalescent Plasma: Now Is the Time for Better Science.
Dzik S |
Transfusion Medicine Reviews | 2020 |
Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement.
Fleming AB, Raabe V |
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | 2020 |
COVID-19 in Newborns and Infants-Low Risk of Severe Disease: Silver Lining or Dark Cloud?
Rawat M, Chandrasekharan P, Hicar MD, Lakshminrusimha S |
American journal of perinatology | 2020 |
Immunoglobulins in the treatment of COVID-19 infection: Proceed with caution!
Nguyen AA, Habiballah SB, Platt CD, Geha RS, Chou JS, McDonald DR |
Clinical Immunology | 2020 |
The Rationale for Potential Pharmacotherapy of COVID-19.
Saber-Ayad M, Saleh MA, Abu-Gharbieh E |
Pharmaceuticals (Basel, Switzerland) | 2020 |
COVID-19 vaccines: Knowing the unknown.
Lv H, Wu NC, Mok CKP |
European Journal of Immunology | 2020 |
From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development.
Ma C, Su S, Wang J, Wei L, Du L, Jiang S |
Microbes and Infection | 2020 |
Prevention and treatment of COVID-19 disease by controlled modulation of innate immunity.
Schijns V, Lavelle EC |
European Journal of Immunology | 2020 |
COVID-19: are neutralizing antibodies neutralizing enough?
Kadkhoda K |
Transfusion | 2020 |
Mild Course of COVID-19 and Spontaneous Virus Clearance in a Patient With Depleted Peripheral Blood B Cells Due to Rituximab Treatment.
Fallet B, Kyburz D, Walker UA |
Arthritis & Rheumatism | 2020 |
A Comprehensive Updated Review on SARS-CoV-2 and COVID-19.
Ren YR, Golding A, Sorbello A, Ji P, Chen J, Saluja B, Witzmann K, Arya V, Reynolds KS, Choi SY, Nikolov NP, Sahajwalla C |
Journal of clinical pharmacology | 2020 |
SARS-CoV-2 and COVID-19: A genetic, epidemiological, and evolutionary perspective.
Sironi M, Hasnain SE, Rosenthal B, Phan T, Luciani F, Shaw MA, Sallum MA, Mirhashemi ME, Morand S, González-Candelas F |
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases | 2020 |
Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment.
Soy M, Keser G, Atagündüz P, Tabak F, Atagündüz I, Kayhan S |
Clinical Rheumatology | 2020 |
Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2.
Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P, Ramnarayan P, Fraisse A, Miller O, Davies P, Kucera F, Brierley J, McDougall M, Carter M, Tremoulet A, Shimizu C, Herberg J, Burns JC, Lyall H, Levin M |
Journal of the American Medical Association | 2020 |
mRNA Vaccines: Possible Tools to Combat SARS-CoV-2.
Yi C, Yi Y, Li J |
Virologica Sinica | 2020 |
Monoclonal antibody as a potential anti-COVID-19.
Jahanshahlu L, Rezaei N |
Biomedicine & Pharmacotherapy | 2020 |
Autoimmunity to ACE2 as a possible cause of tissue inflammation in Covid-19.
Townsend A |
Medical Hypotheses | 2020 |
Role of Monocytes/Macrophages in Covid-19 Pathogenesis: Implications for Therapy.
Gómez-Rial J, Rivero-Calle I, Salas A, Martinón-Torres F |
Infection and drug resistance | 2020 |
Current Status of Laboratory Diagnosis for COVID-19: A Narrative Review.
Russo A, Minichini C, Starace M, Astorri R, Calò F, Coppola N |
Infection and drug resistance | 2020 |
Challenges and prospects of COVID-19 vaccine development based on the progress made in SARS and MERS vaccine development.
Begum J, Mir NA, Dev K, Buyamayum B, Wani MY, Raza M |
Transboundary and Emerging Diseases | 2020 |
SARS-CoV2 vertical transmission with adverse effects on the newborn revealed through integrated immunohistochemical, electron microscopy and molecular analyses of Placenta.
Facchetti F, Bugatti M, Drera E, Tripodo C, Sartori E, Cancila V, Papaccio M, Castellani R, Casola S, Boniotti MB, Cavadini P, Lavazza A |
EBioMedicine | 2020 |
Ramping up of SARS CoV-2 testing for the diagnosis of COVID-19 to better manage the next phase of pandemic and reduce the mortality in India.
Natesan S, Bhatia R, Sundararajan A, Dhama K, Malik YS, Vora K |
VirusDisease | 2020 |
CT Findings in a Novel Coronavirus Disease (COVID-19) Pneumonia at Initial Presentation.
Xiang C, Lu J, Zhou J, Guan L, Yang C, Chai C |
BioMed Research International | 2020 |
[COVID-19, management, therapeutic and vaccine approaches].
Matusik É, Ayadi M, Picard N |
2020 | |
Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19.
Chen X, Pan Z, Yue S, Yu F, Zhang J, Yang Y, Li R, Liu B, Yang X, Gao L, Li Z, Lin Y, Huang Q, Xu L, Tang J, Hu L, Zhao J, Liu P, Zhang G, Chen Y, Deng K, Ye L |
Signal Transduction and Targeted Therapy | 2020 |
Nanotheranostics against COVID-19: From multivalent to immune-targeted materials.
Hassanzadeh P |
Journal of Controlled Release | 2020 |
The potential threat of multisystem inflammatory syndrome in children during the COVID-19 pandemic.
Rothan HA, Byrareddy SN |
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology | 2020 |
A comprehensive, longitudinal analysis of humoral responses specific to four recombinant antigens of SARS-CoV-2 in severe and non-severe COVID-19 patients.
Chen Y, Tong X, Li Y, Gu B, Yan J, Liu Y, Shen H, Huang R, Wu C |
PLoS pathogens | 2020 |
Antibody-dependent enhancement of coronavirus.
Wen J, Cheng Y, Ling R, Dai Y, Huang B, Huang W, Zhang S, Jiang Y |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2020 |
The Challenges of Vaccine Development against Betacoronaviruses: Antibody Dependent Enhancement and Sendai Virus as a Possible Vaccine Vector.
Zaichuk TA, Nechipurenko YD, Adzhubey AA, Onikienko SB, Chereshnev VA, Zainutdinov SS, Kochneva GV, Netesov SV, Matveeva OV |
Molecular Biology | 2020 |
Vaccines for COVID-19.
Tregoning JS, Brown ES, Cheeseman HM, Flight KE, Higham SL, Lemm NM, Pierce BF, Stirling DC, Wang Z, Pollock KM |
Clinical & Experimental Immunology | 2020 |
Update on serologic testing in COVID-19.
Krajewski R, Gołębiowska J, Makuch S, Mazur G, Agrawal S |
Clinica chimica acta; international journal of clinical chemistry | 2020 |
A 63-Year-Old Woman with a History of Non-Hodgkin Lymphoma with Persistent SARS-CoV-2 Infection Who Was Seronegative and Treated with Convalescent Plasma.
Moore JL, Ganapathiraju PV, Kurtz CP, Wainscoat B |
2020 | |
Enhanced elicitation of potent neutralizing antibodies by the SARS-CoV-2 spike receptor binding domain Fc fusion protein in mice.
Liu X, Drelich A, Li W, Chen C, Sun Z, Shi M, Adams C, Mellors JW, Tseng CT, Dimitrov DS |
Vaccine | 2020 |
Successful transfer of anti-SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19.
Luetkens T, Metcalf R, Planelles V, Zheng Y, Larragoite ET, Spivak ES, Spivak AM, Steinbach M, Blaylock RC, Avila SV, Hankey KG, Martins TB, Slev PR, Mannuel HD, Sajadi M, Rapoport AP, Atanackovic D |
Blood Advances | 2020 |
Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement.
Chen WH, Tao X, Agrawal AS, Algaissi A, Peng BH, Pollet J, Strych U, Bottazzi ME, Hotez PJ, Lustigman S, Du L, Jiang S, Tseng CK |
Vaccine | 2020 |
A systematic review of SARS-CoV-2 vaccine candidates.
Dong Y, Dai T, Wei Y, Zhang L, Zheng M, Zhou F |
Signal Transduction and Targeted Therapy | 2020 |
Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial.
Usmani SS, Raghava GPS |
Frontiers in immunology | 2020 |
Role of Systemic and Nasal Glucocorticoid Treatment in the Regulation of the Inflammatory Response in Patients with SARS-Cov-2 Infection.
Cárdenas G, Torres-García D, Cervantes-Torres J, Rosales-Mendoza S, Fleury A, Fragoso G, Laclette JP, Sciutto E |
Archives of Medical Research | 2020 |
Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19.
Cervia C, Nilsson J, Zurbuchen Y, Valaperti A, Schreiner J, Wolfensberger A, Raeber ME, Adamo S, Weigang S, Emmenegger M, Hasler S, Bosshard PP, De Cecco E, Bächli E, Rudiger A, Stüssi-Helbling M, Huber LC, Zinkernagel AS, Schaer DJ, Aguzzi A, Kochs G, Held U, Probst-Müller E, Rampini SK, Boyman O |
Journal of Allergy and Clinical Immunology | 2020 |
Recommendations for the Diagnosis, Prevention, and Control of Coronavirus Disease-19 in Children-The Chinese Perspectives.
Fang F, Chen Y, Zhao D, Liu T, Huang Y, Qiu L, Hao Y, Hu X, Yin W, Liu Z, Jin R, Ning Q, Cheung PT, Liu C, Shu S, Wang T, Luo X |
Frontiers in Pediatrics | 2020 |
Seroprevalence of SARS-CoV-2 in Hong Kong and in residents evacuated from Hubei province, China: a multicohort study.
To KK, Cheng VC, Cai JP, Chan KH, Chen LL, Wong LH, Choi CY, Fong CH, Ng AC, Lu L, Luo CT, Situ J, Chung TW, Wong SC, Kwan GS, Sridhar S, Chan JF, Fan CY, Chuang VWM, Kok KH, Hung IF, Yuen KY |
2020 | |
Low toxicity and high immunogenicity of an inactivated vaccine candidate against COVID-19 in different animal models.
Wang ZJ, Zhang HJ, Lu J, Xu KW, Peng C, Guo J, Gao XX, Wan X, Wang WH, Shan C, Zhang SC, Wu J, Yang AN, Zhu Y, Xiao A, Zhang L, Fu L, Si HR, Cai Q, Yang XL, You L, Zhou YP, Liu J, Pang DQ, Jin WP, Zhang XY, Meng SL, Sun YX, Desselberger U, Wang JZ, Li XG, Duan K, Li CG, Xu M, Shi ZL, Yuan ZM, Yang XM, Shen S |
Emerging Microbes & Infections | 2020 |
Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review
Ortiz-Prado E, Simbaña-Rivera K, Gómez- Barreno L, Rubio-Neira M, Guaman LP, Kyriakidis NC, Muslin C, Jaramillo AM, Barba-Ostria C, Cevallos-Robalino D, Sanches-SanMiguel H, Unigarro L, Zalakeviciute R, Gadian N, López-Cortés A |
Diagnostic Microbiology and Infectious Disease | 2020 |
Fighting the Host Reaction to SARS-COv-2 in Critically Ill Patients: The Possible Contribution of Off-Label Drugs
Scala S, Pacelli R |
Frontiers in immunology | 2020 |
A potentially effective treatment for COVID-19: A systematic review and meta-analysis of convalescent plasma therapy in treating severe infectious disease
Sun M, Xu Y, He H, Zhang L, Wang X, Qiu Q, Sun C, Guo Y, Qiu S, Ma K |
International Journal of Infectious Diseases | 2020 |
Energetics and IC50 based epitope screening in SARS CoV-2 (COVID 19) spike protein by immunoinformatic analysis implicating for a suitable vaccine development
Banerjee A, Santra D, Maiti S |
Journal of Translational Medicine | 2020 |
Immune-mediated approaches against COVID-19
Florindo HF, Kleiner R, Vaskovich-Koubi D, Acúrcio RC, Carreira B, Yeini E, Tiram G, Liubomirski Y, Satchi-Fainaro R |
Nature Nanotechnology | 2020 |
Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions
Jafarzadeh A, Chauhan P, Saha B, Jafarzadeh S, Nemati M |
Life Sciences | 2020 |
SARS-CoV-2-specific ELISA development
Roy V, Fischinger S, Atyeo C, Slein M, Loos C, Balazs A, Luedemann C, Astudillo MG, Yang D, Wesemann DR, Charles R, Lafrate AJ, Feldman J, Hauser B, Caradonna T, Miller TE, Murali MR, Baden L, Nilles E, Ryan E, Lauffenburger D, Beltran WG, Alter G |
Journal of Immunological Methods | 2020 |
SARS-CoV-2 neutralizing antibody levels are correlated with severity of COVID-19 pneumonia
Chen W, Zhang J, Qin X, Wang W, Xu M, Wang LF, Xu C, Tang S, Liu P, Zhang L, Liu X, Zhang Y, Yi C, Hu Z, Yi Y |
Biomedicine & Pharmacotherapy | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Folegatti PM, Ewer KJ, Aley PK, Angus B, Becker S, Belij-Rammerstorfer S, Bellamy D, Bibi S, Bittaye M, Clutterbuck EA, Dold C, Faust SN, Finn A, Flaxman AL, Hallis B, Heath P, Jenkin D, Lazarus R, Makinson R, Minassian AM, Pollock KM, Ramasamy M, Robinson H, Snape M, Tarrant R, Voysey M, Green C, Douglas AD, Hill AV, Lambe T, Gilbert SC, Pollard AJ |
2020 | |
The DHODH inhibitor PTC299 arrests SARS-CoV-2 replication and suppresses induction of inflammatory cytokines
Luban J, Sattler RA, Mühlberger E, Graci JD, Cao L, Weetall M, Trotta C, Colacino JM, Bavari S, Strambio-De-Castillia C, Suder EL, Wang Y, Soloveva V, Cintron-Lue K, Naryshkin NA, Pykett M, Welch EM, O\u2019Keefe K, Kong R, Goodwin E, Jacobson A, Paessler S, Peltz SW |
Virus Research | 2020 |
COVID-19 vaccines: The status and perspectives in delivery points of view
Chung JY, Thone MN, Kwon YJ |
Advanced Drug Delivery Reviews | 2020 |
A highly immunogenic and effective measles virus-based Th1-biased COVID-19 vaccine
Hörner C, Schürmann C, Auste A, Ebenig A, Muraleedharan S, Dinnon KH III, Scholz T, Herrmann M, Schnierle BS, Baric RS, Mühlebach MD |
Proceedings of the National Academy of Sciences | 2020 |
RNA Vaccines: A Suitable Platform for Tackling Emerging Pandemics?
Sandbrink JB, Shattock RJ |
Frontiers in immunology | 2020 |
Severe Acute Respiratory Syndrome Coronavirus-2 Induces Cytokine Storm and Inflammation During Coronavirus Disease 19: Perspectives and Possible Therapeutic Approaches
Mannino F, Bitto A, Irrera N |
Frontiers in pharmacology | 2020 |
Severe Coronavirus Disease 2019 That Recovered from Respiratory Failure by Treatment That Included High-dose Intravenous Immunoglobulin
Suzuki Y, Tanino Y, Nikaido T, Minemura H, Umeda T, Rikimaru M, Onuma T, Naito S, Takiguchi Y, Tomita H, Kawamata T, Togawa R, Sato Y, Uematsu M, Morimoto J, Kitakawa K, Tsukada Y, Nakamura K, Kanemitsu K, Iseki K, Shibata Y |
Internal Medicine | 2020 |
Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel
Adams ER, Ainsworth M, Anand R, Andersson MI, Auckland K, Baillie JK, Barnes E, Beer S, Bell JI, Berry T, Bibi S, Carroll M, Chinnakannan SK, Clutterbuck E, Cornall RJ, Crook DW, de Silva T, Dejnirattisai W, Dingle KE, Dold C, Espinosa A, Eyre DW, Farmer H, Fernandez Mendoza M, Georgiou D, Hoosdally SJ, Hunter A, Jefferey K, Kelly DF, Klenerman P, Knight J, Knowles C, Kwok AJ, Leuschner U, Levin R, Liu C, López-Camacho C, Martinez J, Matthews PC, McGivern H, Mentzer AJ, Milton J, Mongkolsapaya J, Moore SC, Oliveira MS, Pereira F, Perez E, Peto T, Ploeg RJ, Pollard A, Prince T, Roberts DJ, Rudkin JK, Sanchez V, Screaton GR, Semple MG, Slon-Campos J, Skelly DT, Smith EN, Sobrinodiaz A, Staves J, Stuart DI, Supasa P, Surik T, Thraves H, Tsang P, Turtle L, Walker AS, Wang B, Washington C, Watkins N, Whitehouse J |
Wellcome Open Research | 2020 |
Progress and Challenges in the Development of COVID-19 Vaccines and Current Understanding of SARS-CoV-2- Specific Immune Responses
Kim KD, Hwang I, Ku\u2020 KB, Lee S, Kim SJ, Kim C |
Journal of Microbiology and Biotechnology | 2020 |
Germline immunoglobulin genes: disease susceptibility genes hidden in plain sight?
Collins AM, Yaari G, Shepherd AJ, Lees W, Watson CT |
Current Opinion in Systems Biology | 2020 |
Convalescent Plasma in COVID-19
Banwait RS, Salabei JK, Fishman TJ, Iyer UG |
2020 | |
[Progress and analysis on the development of 2019-nCoV vaccine].
Kang Z, Tang M |
Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi | 2020 |
Establishment of an African green monkey model for COVID-19
Woolsey C, Borisevich V, Prasad AN, Agans KN, Deer DJ, Dobias NS, Heymann JC, Foster SL, Levine CB, Medina L, Melody K, Geisbert JB, Fenton KA, Geisbert TW, Cross RW |
2020 | |
Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1) Formulated with Aluminum Hydroxide Induces Protective Immunity and Reduces Immune Enhancement
Chen WH, Tao X, Agrawal A, Algaissi A, Peng BH, Pollet J, Strych U, Bottazzi ME, Hotez PJ, Lustigman S, Du L, Jiang S, Tseng CT |
2020 | |
Detection of antibodies to the SARS-CoV-2 spike glycoprotein in both serum and saliva enhances detection of infection
Faustini SE, Jossi SE, Perez-Toledo M, Shields AM, Allen JD, Watanabe Y, Newby ML, Cook A, Willcox CR, Salim M, Goodall M, Heaney JL, Marcial-Juarez E, Morley GL, Torlinska B, Wraith DC, Veenith TV, Harding S, Jolles S, Ponsford MJ, Plant T, Huissoon A, O\u2019Shea MK, Willcox BE, Drayson MT, Crispin M, Cunningham AF, Richter AG |
2020 | |
COVID-19 neutralizing antibodies predict disease severity and survival
Garcia-Beltran WF, Lam EC, Astudillo MG, Yang D, Miller TE, Feldman J, Hauser BM, Caradonna TM, Clayton KL, Nitido AD, Murali MR, Alter G, Charles RC, Dighe A, Branda JA, Lennerz JK, Lingwood D, Schmidt AG, Iafrate AJ, Balazs AB |
2020 |